Loading company…
Sensible is a biotechnology company developing a cell-based mRNA design, optimization and manufacturing platform for therapeutics.
Founded in 2021 and based in the UK, Sensible develops a cell-based mRNA design, optimization and manufacturing platform for therapeutic applications. The company is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in